Breaking News

Agilent Introduces OneSight

March 9, 2016

Allows researchers to analyze chromosomal aneuploidies in cell-free DNA sequencing data in-house

Agilent Technologies Inc. has introduced OneSight, a new software platform designed to help researchers visualize and analyze chromosomal aneuploidies in cell-free DNA sequencing data in-house.
“The study of cell-free DNA is a very active area of research, and we expect growth in applications such as analysis of liquid biopsies and cell-free fetal DNA,” said Herman Verrelst, Agilent vice president and general manager of the company’s Genomics Solutions Division and Clinical Applications Division. “With OneSight, researchers will be able to gain a deeper understanding of their sequencing data and apply that to a wide range of applications, from the early detection of cancer to screening for fetal abnormalities.”
The software platform is independent of NGS sequencing technology. With an established NGS infrastructure in place, OneSight allows labs to set up an end-to-end cfDNA analysis pipeline. According to the company, through the new platform’s visualization tools and statistical parameters, scientists can minimize the impact of recurrent technical variations and assess the presence of confounding biological factors such as segmental aberrations and genome-wide chromosomal instability.
The new software was developed with expertise from Cartagenia, a company Agilent acquired last year.
blog comments powered by Disqus
  • Packaging Equipment Close-Up

    Packaging Equipment Close-Up

    Kristin Brooks, Contract Pharma||March 9, 2016
    To meet the wide-ranging needs of the marketplace, suppliers and contract packagers are looking to deliver flexible solutions.

  • Cold-Chain Logistics & The Central Lab

    Kristin Brooks, Associate Editor||January 28, 2016
    Eric Hayashi of LabConnect discusses safety measures to ensure sample integrity

  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements